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Abstract
Background: Type 2 diabetes and depression are common diseases with bidirectional
associations. Depression in diabetics leads to poor adherence to diet and medication,
poor glycemic control, reduced quality of life, and increased diabetes-related
healthcare expenditure. This study aimed at evaluating diabetic patients with
depression to improve the quality of care delivered.
Materials and Methods: An institution-based cross-sectional study was conducted
among adult type 2 diabetics at Al-Jemaih Diabetic Center, Dongola, in July–
December 2019A standardized pretested questionnaire was used to collect data, and
the depression subscale of the Patient Health Questionnaire was used to diagnose
depression. Chi-square test and logistic regression were used to analyze the data
using the Statistical Package for Social Sciences version 25.0.
Results:Out of the 407 participants, 282 (69.3%) were females, andmore than half were
aged between 40 and 59 years. The prevalence of depression among type 2 diabetic
patients was 35.6%, ranging from mild (24.3%) to moderate (7.4%), moderately severe
(2.2%), and severe depression (1.7%). The risk factors associated with depression in
type 2 diabetes were: combining antidiabetic therapy, long duration of diabetes, family
history of psychiatric illness, diabetes-related complications, poor glycemic control, and
lack of regular exercise.
Conclusion:More than a third of type 2 diabetics have depression. Screening diabetic
patients for depression, establishing a psychiatric unit at the diabetic center, and
community-based studies are recommended.
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1. Introduction
The worldwide number of diabetic patients is rising to pandemic levels [1]. The estimated
total number of diabetics was 463 million in 2019 and is expected to increase by 51% to
700 million cases in 2045 [1]. The global rise of the diabetic population is more likely to
affect low-and middle-income countries than the high-income ones. In the Middle East
and North African (MENA) region, diabetic estimates will rise by 96% from 55 million in
2019 to 108 million in 2045 [2]. Sudan was included among the top five countries with
the highest prevalence of diabetics in the MENA region in 2019; with a prevalence of
17.9%, a total of 3.7 million cases, and one in every six adults with diabetes [3]. Previous
studies demonstrated high prevalence rates of diabetes in North Sudan compared to
the other parts of the country [4, 5]. Moreover, a strong association has been observed
between diabetes mellitus (DM) and mental disorders like depression.
Depression is a common mental problem, with a global prevalence of 2–6% in 2017,
affecting more than 264 million people and tends to increase with age [6, 7]. The
overall prevalence of depression in Sudan was 3.78% in 2017 [7]. Depression is common
among diabetic patients and is considered a modifiable risk factor for type 2 diabetes
mellitus (T2DM) as well as for the progression of diabetes-related complications [8].
Having T2DM more than doubles the risk of depression, and concurrent depression
with diabetes is associated with poor adherence to diet and medication, poor glycemic
control, reduced quality of life, and increased diabetes-related healthcare expenditure
[9]. Therefore, it is important to evaluate diabetic patients for depression to improve the
quality of care delivered.
In different studies, two types of validated questionnaires were used to screen
diabetic patients for depression: the Patient Health Questionnaire (PHQ-9) and the
depression subscale of the Hospital Anxiety and Depression Scale (HADS-D). Both
questionnaires have been effectively used in different studies among diabetic patients
[8, 10, 11]. PHQ is a self-administered version of the primary care evaluation of mental
disorders (PRIME-MD®) instrument used for primary care diagnosis of mental disorders,
while the PHQ-9 subscale is used for depression [12].
Literature review revealed one study about the prevalence of depression among
T2DM patients in Central Sudan (Omdurman) using the HADS questionnaire [13]. Thus
far, no study has explored depression among diabetics in the Northern State, Sudan,
despite the high prevalence rate of diabetes. Therefore, this study aimed to deter-
mine the prevalence and associated factors of depression among adult T2DM patients
attending regular follow-up at Al-Jemaih Diabetic Center in Dongola, Northern State,
Sudan.
2. Materials and Methods
2.1. Study design, area, and population
An analytical cross-sectional study was carried out among adults with T2DM attending
regular follow-up at the Al-Jemaih Diabetic Center in Dongola, the capital city of the
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Northern State, Sudan, during the period from July 1 to December 30, 2019. The center
was initially established in 2003 and then inaugurated after the development as well as
renewal by the Al-Jemaih Charity Organization (Kingdom of Saudi Arabia) in April 2018.
The center offers medical services at primary, secondary, and tertiary levels to diabetic
patients from the whole state. To date, 10,163 diabetic patients including 119 diabetic
children have been registered and about 150–250 patients are seen daily.
2.2. Sample size determination
The study population included all adult T2DM patients registered at the center and
attending routine follow-up during the study period. The minimum sample size was
379, calculated using the following formula:
𝑧2𝑃 (1 − 𝑃 )
𝑑2 ,
When the prevalence of depression among DM in Sudan was considered as 44% [13]
with 95% confidence interval and 5% precision.
2.3. Ethical considerations
Ethical approval was obtained from the Research Ethics Committee at the State Min-
istry of Health. Informed consent was taken from each participant. Participants with
moderate-to-severe depression were recommended to be seen by a psychiatrist for
further assessment and management.
2.4. Data collection
All adult T2DM patients attending the clinic during the study period were invited to
participate. A convenient sampling method was used to select the participants. Those
who did not agree to participate, children aged <18 years, type 1 diabetic patients, and
those who had a recent psychiatric illness or suffered from recent (within one month)
loss of a first-degree relative or spouse were excluded from the study. A standardized
pretested questionnaire was used to collect data. The questionnaire included personal
data, duration, treatment, compliance, follow-up and complications of DM, history of
chronic illness or long-term medication, history of tobacco or alcohol use or drug abuse,
and family history of psychiatric disease. The participant was considered as having
controlled DM if a recent (within three months) glycosylated hemoglobin (HbA1c) level
was <7 and uncontrolled if the HbA1c level was ≥7. The PHQ-9 was used as a validated
screening tool for detecting depression among diabetic patients [12, 14] after it was
translated in Arabic and the translation was reviewed by an expert. A pilot sample of 30
respondents was used to measure the reliability of the Arabic-translated PHQ-9 (0.778;
95%CI: 0.744–0.809) using Cronbach’s alpha test. Two general medical practitioners
were trained in data collection to explain to the patients in a simple local language,
especially those who were not fluent in Arabic. PHQ-9 scores range from 0 (not at all)
to 3 (nearly every day) for the nine diagnostic criteria of depression encountered within
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the last two weeks [15]. While the total score ranges from 0 to 27 [15], the total PHQ-9
score of participants is categorized as following: 0–4 = no or minimal depression, 5–9 =
mild depression, 10–14 = moderate depression, 15–19 = moderately severe depression,
and 20–27 = severe depression [15]. The participants with score ≥5 were classified as
having depression in the further analysis.
2.5. Data analysis
Frequency percentage was used to determine the depression prevalence of various
degrees of depression, which has been displayed in a histogram. To determine risk
factors for depression among diabetic patients, both Chi-square and binary logistic
regression were used. Odds ratios (OR) with a confidence interval (CI) were used to
present the logistic regression results. P-value < 0.05 was considered statistically
significant. All analyses were done using the Statistical Package for Social sciences
(SPSS), version 25.0. (Armonk, New York: IBM Corp, USA).
3. Results
A total of 407 diabetic patients were included in the study, of which 282 (69.3%)
were females and 125 (30.7%) males. The study observed that more than half of the
respondents were aged between 40 and 59 years, belonged to the Danaglah tribe,
and had an education level below the university degree. In addition, more than two-
thirds (69.8%) of the diabetic patients in our study were treated by oral hypoglycemic,
and almost one-third (33.2%) of them had diabetes-related complications. The majority
(82.6%) of the participants had poor glycemic control, and 11.8% of the respondents had
a family history of psychiatric illness, while more than half (54%) of the study population
did not practice regular excise. Chi-square test found that the prevalence of depression
among diabetics was significantly increasedwith long diabetic duration, type of diabetes
treatment, presence of complications, family history of psychiatric disease, glycemic
control, and exercise status, as shown in Table 1.
The overall prevalence of depression among diabetic patients was 35.6%, ranging
from mild to severe forms of depression, whereas the prevalence of major depression
(moderate to severe or PHQ-9 score of ≥10) was 11.3%, as shown in Figure 1.
Binary logistic regression indicates a positive association between the duration of
diabetes and prevalence of depression; whereas diabetic patients with the longer
duration (≥20 years) weremore than three times (OR = 3.55; 95%CI: 1.76–7.13) more likely
to have depression compared to those with shorter duration (<5 years). Patients treated
with a combination of oral hypoglycemic drugs and insulin were more than four times
(OR = 4.26; 95%CI: 1.02–17.86) more likely to have depression than those treated only
through dietary control. Furthermore, uncontrolled diabetics and those with diabetes-
related complications, family history of psychiatric disease, and those who had never
performed physical exercise were almost twice (OR = 1.80; 95%CI: 1.00–3.19), (OR =
1.97; 95%CI: 1.07–3.61), and (OR = 1.98; 95%CI: 1.07–3.61) more likely to have depression
compared to other groups, as shown in Table 2.
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TABLE 1: Baseline characteristics of adult type 2 diabetic patients and the prevalence of depression in
Al-Jemaih diabetic center, Dongola, Northern State, Sudan, 2019.





Total 407 (100) 145 (35.6) 262 (64.4) –
Age
<40 years 49 (12) 18 (36.7) 31 (63.3) 0.260
40–59 years 228 (56) 88 (38.6) 140 (61.4)
≥60 years 130 (31.9) 39 (30.0) 91 (70.0)
Gender
Male 125 (30.7) 44 (35.2) 81 (64.8) 0.905
Female 282 (69.3) 101 (35.8) 181 (64.2)
Tribes
Danaglah 223 (54.8) 75 (33.6) 148 (66.4) 0.140
Mahass 50 (12.3) 21 (42.0) 29 (58.0)
Halab 43 (10.6) 21 (48.8) 22 (51.2)
Others 91 (22.4) 28 (30.8) 63 (69.2)
Education
Illiterate 171 (42) 58 (33.9) 113 (66.1) 0.670
Pre-university 205 (50.4) 76 (37.1) 129 (62.9)
University & above 31 (7.6) 11 (35.5) 20 (64.5)
DM duration
<5 years 124 (30.5) 31 (25.0) 93 (75.0) 0.008
5–10 years 125 (30.7) 46 (36.8) 79 (63.2)
10–15 years 66 (16.2) 25 (37.9) 41 (62.1)
15–20 years 44 (10.8) 17 (38.6) 27 (61.4)
≥20 years 48 (11.8) 26 (54.2) 22 (45.8)
Type of treatment
Diet only 12 (2.9) 3 (25.0) 9 (75.0)
Oral hypoglycemic 284 (69.8) 87 (30.6) 197 (69.4) 0.001
Insulin 65 (16) 28 (43.1) 37 (56.9)
Combined (insulin &
tablets)
46 (11.3) 27 (58.7) 19 (41.3)
DM complications
Yes 135 (33.2) 59 (43.7) 76 (56.3) 0.017
No 272 (66.8) 86 (31.6) 186 (68.4)
Family history of
psychiatric
Yes 48 (11.8) 24 (50.0) 24 (50.0) 0.027
No 359 (88.2) 121 (33.7) 238 (66.3)
Glycemic control
(HbA1c)
Controlled 71 (17.4) 18 (25.4) 53 (74.6) 0.047
Uncontrolled 336 (82.6) 127 (37.8) 209 (62.2)
Exercise
Yes 187 (49.9) 54 (28.9) 133 (71.1) 0.009
No 220 (54.1) 91 (41.4) 129 (58.6)
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Figure 1: Prevalence of different levels of depression among adult type 2 diabetic patients at the Al-Jemaih
Diabetic Center in Dongola, Northern State, Sudan, 2019.
TABLE 2: Factors associated with the prevalence of depression among adult type 2 diabetic patients at the
Al-Jemaih Diabetic Center in Dongola, Northern State, Sudan, 2019.
Variable OR (95%CI) P-value
Duration of DM
<5 years Reference
5–10 years 1.75 (1.01–3.01) 0.045
10–15 years 1.83 (0.96–3.47) 0.065
15–20 years 1.89 (0.91–3.92) 0.088
≥20 years 3.55 (1.76–7.13) <0.001
Type of treatment
Diet only Reference
Oral hypoglycemic 1.32 (0.35–5.01) 0.679
Insulin 2.27 (0.56–9.17) 0.250
Combined (insulin & tablets) 4.26 (1.02–17.86) 0.047
Glycemic control
Yes Reference
No 1.80 (1.00–3.19) 0.049
DM complication
No Reference
Yes 1.97 (1.07–3.61) 0.029
Family history of psychiatric
No Reference
Yes 1.98 (1.07–3.61) 0.029
Exercise
Yes Reference
No 1.74 (1.15–2.63) 0.009
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4. Discussion
Depression is common among diabetic patients and affects diabetics in terms of morbid-
ity and mortality. Our study showed a lower prevalence rate of depression compared to
a previous study among T2DM in Omdurman Locality, Khartoum State, with a prevalence
rate of depression of 44% [13]. The difference may be partially explained by the different
scoring systems; while the study in Khartoum State used the HADS questionnaire, this
study used the PHQ-9 score. Besides, our prevalence was also lower than most of the
international studies assessing depression in T2DM using PHQ-9 score. A study from
Suez Canal University Hospital in Egypt revealed a rate of depression of 69% in patients
with T2DM [16], while a study conducted in Ethiopia showed a depression rate of 54.2%
[17]. Two studies from India showed that the prevalence rates of depression were 41%
and 62% among T2DM [18, 19]. The rate of depression in T2DM varies greatly among
different sub-Saharan African and Middle Eastern countries, ranging from as low as 15%
in Nigeria and 20% in Jordan and Oman to as high as 70% in Iran [20]. The prevalence
of major depression was 11.3%, slightly low compared to that of the study from Ethiopia
with 13% [17]. The relatively low prevalence of depression among T2DM in the northern
states compared to the national and international studies might be explained by the
good family support of diabetic patients and good community awareness about DM as
it is a common disease.
This study revealed that the risk factors associated with depression in T2DM were:
combined antidiabetic therapy (OR = 4.26), long duration of diabetes (OR = 3.55),
family history of psychiatric illness (OR = 1.98), diabetes-related complications (OR =
1.97), poor glycemic control (OR = 1.80), and lack of regular exercise (OR = 1.74). The
rates of depression showed no significant difference regarding age, gender, tribe, and
educational level. The observed association between combined antidiabetic therapy
and depression concurs with an earlier meta-analysis that explored the association
between insulin treatment and depression in T2DM; it revealed that insulin therapy
was associated with a higher risk of depression [21]. This might be explained by the
reluctance of T2DM patients to take insulin as a last option for uncontrolled DM as
well as taking multiple medications with increased cost. Other reasons include the long
duration of T2DM as most patients start insulin late as well as the presence of diabetes-
related complications and comorbidities. Regarding the duration of T2DM, symptoms
of depression tend to increase early after diagnosis and decrease over a few years and
then rise with the longer duration of DM, making a j-shaped curve; the rise with the
duration of DM may be related to frailty associated with old age and longer duration
[22]. Many studies have demonstrated the significant association between depression
in T2DM and diabetes-related complications, poor glycemic control, and lack of exercise
[23–27]. The family history as a risk factor may be explained by a potential common
genetic susceptibility to both T2DM and depression [28], but no study has mentioned a
family history of psychiatric illness as a risk factor for depression in T2DM. Interestingly,
the depression rate was more common in females than males, but the association was
not statistically significant. Most studies considered female gender a significant risk
factor for depression in T2DM [22, 25–27].
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Limitations: The current study had the following limitations: first, it was a cross-
sectional study, which could not determine the causal factors of depression in T2DM
patients; second, it was conducted at an institutional but not at the community level
as more depressed diabetics might be seen at the diabetic center indicating possible
selection bias. However, this is the first study conducted in the Northern State, a state
with high prevalence rates of DM in Sudan, and most likely the second study in Sudan,
thus adding new insight to a common problem among diabetics. The study also enrolled
a reasonable sample size with a high response rate. Moreover, the cross-sectional study
design would give a quick snapshot of the depression rate among diabetic patients in
the state for future interventions.
5. Conclusion
Our study shows that more than a third of T2DM have depression. Risk factors for
depression in T2DM include combined insulin and oral hypoglycemic drug therapy, long
duration of T2DM, family history of psychiatric disease, diabetes-related complications,
poor glycemic control, and lack of exercise. Screening for depression as well as other
psychiatric disorders in all diabetics at the center is necessary and healthcare staff
providing diabetic care should be able to diagnose, manage, or refer diabetic patients
with depression. The establishment of a psychiatric unit at the center is recommended.
Further longitudinal large-scale studies and qualitative studies are recommended for
in-depth assessment of depression, anxiety, and other psychiatric disorders among
diabetic as well as nondiabetic populations.
Acknowledgements
The authors would like to express their gratitude to the staff of Al-Jemaih Diabetic
Center for their great help in carrying out the study at the center. They are also thankful
to the patients who agreed to participate in the study.
Ethical considerations
Ethical approval was obtained from the Ethics Committee of the State Ministry of Health,
Northern State, Sudan.
Competing interests
The authors declare hereby that there are no conflicts of interest.
Availability of data and materials
All data are available upon reasonable request.
DOI 10.18502/sjms.v15i4.8163 Page 415
Sudan Journal of Medical Sciences Mohamed Osman Abdelaziz et al
Funding
No funding was received from any governmental or nongovernmental institution.
Authors’ Contributions
Abdelaziz MO and Alzain MA participated in developing the research concept and
design as well as in the training and supervision of the data collectors. Abdakhaleg MA
performed data collection. Abdelaziz MO carried out data entry and Alzain MA carried
out data analysis using SPSS. All authors participated in writing, editing, and approving
the final manuscript.
Disclosure:
This article or the abstract was not presented in any conference nor it was submitted
to any other journal for publication
References
[1] Huizinga, M. M. and Rothman, R. L. (2006). Addressing the diabetes pandemic: a com-
prehensive approach. Indian Journal of Medical Research, vol. 124, no. 5, pp. 481–484.
Retrieved from https://search.proquest.com/openview/b6814b4ac9d1c29a8fa59e12e6473d10/1?pq-
origsite=gscholar&cbl=37533 (accessed August 1, 2020).
[2] IDF. (2019). IDF Atlas 2019 Fact sheet (9𝑡ℎ ed.). Retrieved from https://www.diabetesatlas.org/en/
resources/ (accessed August 8, 2020).
[3] IDF. (2019). IDF Atlas 2019 Fact sheet: MENA (9𝑡ℎ ed.). Retrieved from https://www.idf.org/our-network/
regions-members/middle-east-and-north-africa/diabetes-in-mena.html (accessed August 8, 2020).
[4] Elbagir, M., Eltom, M., Elmahadi, E., et al. (1998). A high prevalence of diabetes mellitus and impaired
glucose tolerance in the Danagla community in Northern Sudan.Diabetic Medicine, vol. 15, pp. 164–169.
[5] Eltom, M. A., Mohamed, A. H., Elrayah-Eliadarous, H., et al. (2018). Increasing prevalence of type 2
diabetes mellitus and impact of ethnicity in north Sudan. Diabetes Research and Clinical Practice, vol.
136, pp. 93–99. Retrieved from https://doi.org/10.1016/j.diabres.2017.11.034
[6] WHO. (2017). Depression and Other Common Mental Disorders: Global Health Estimates. Geneva:
World Health Organization. License: CC BY-NC-SA 3.0 IGO. Retrieved from https://apps.who.int/iris/
bitstream/handle/10665/254610/WHO-MSD-MER-2017.2-eng.pdf (accessed on August 8, 2020).
[7] Ritchie, H. and Roser, M. (2019).Mental Health. Retrieved from https://ourworldindata.org/mental-health
(accessed on August 01, 2020).
[8] Thour, A., Das, S., Sehrawat, T., et al. (2015). Depression among patients with diabetes mellitus in North
India evaluated using patient health questionnaire-9. Indian Journal of Endocrinology and Metabolism,
vol. 19, no. 2, pp. 252–255. doi:10.4103/2230-8210.149318
[9] Lustman, P. J. and Clouse, R. E. (2005). Depression in diabetic patients: the relationship between mood
and glycemic control. Journal of Diabetic Complications, vol. 19, no. 2, pp. 113–122. Retrieved from
https://doi.org/10.1016/j.jdiacomp.2004.01.002
[10] Reddy, P., Philpot, B., Ford, D., et al. (2010). Identification of depression in diabetes: the efficacy of
PHQ-9 and HADS-D. British Journal of General Practice, vol. 60, no. 575, pp. e239–e245. Retrieved
from https://doi.org/10.3399/bjgp10X502128
[11] van Steenbergen-Weijenburg, K. M., de Vroege, L., Ploeger, R. R., et al. (2010). Validation of the PHQ-9
as a screening instrument for depression in diabetes patients in specialized outpatient clinics. BMC
Health Services Research, vol. 10, p. 235. Retrieved from https://doi.org/10.1186/1472-6963-10-235
[12] Kroenke, K., Spitzer, R. L., and Williams, J. B. (2001). The PHQ-9: validity of a brief depression severity
measure. Journal of General Internal Medicine, vol. 16, no. 9, pp. 606–613. Retrieved from https:
//doi.org/10.1046/j.1525-1497.2001.016009606.x
DOI 10.18502/sjms.v15i4.8163 Page 416
Sudan Journal of Medical Sciences Mohamed Osman Abdelaziz et al
[13] Mirghani, H. O., Mohammed, O. S., and Saadallah, A. M. (2014). Prevalence of depression among
Sudanese patients with type 2 diabetes mellitus. Sudan Journal of Medical Sciences, vol. 9, no. 3, pp.
151–155. Retrieved from https://www.ajol.info/index.php/sjms/article/view/114285
[14] Udedi, M., Muula, A. S., Stewart, R. C., et al. (2019). The validity of the patient health Questionnaire-9 to
screen for depression in patients with type-2 diabetes mellitus in non-communicable diseases clinics
in Malawi. BMC Psychiatry, vol. 19, p. 81. Retrieved from https://doi.org/10.1186/s12888-019-2062-2
[15] Kroenke, K., Spitzer, R. L., and Williams, J. B. (2001). The PHQ-9: validity of a brief depression severity
measure. Journal of General Internal Medicine, vol. 16, no. 9, pp. 606–613. Retrieved from https:
//doi.org/10.1046/j.1525-1497.2001.016009606.x
[16] Ismail, M. F. S., Fares, M. M., and Abd-Alrhman, A. G. (2019). Prevalence of depression and predictors
of glycemic control among type 2 diabetes mellitus patients at family medicine clinic, Suez Canal
University Hospital Egypt. World Family Medicine, vol. 17, no. 2, pp. 4–13. Retrieved from https://pdfs.
semanticscholar.org/4173/a0e90cd797877e0205929048e919593c7d2d.pdf
[17] Habtewold, T. D., Radie, Y. T., and Sharew, N. T. (2015). Prevalence of depression among type 2
diabetic outpatients in Black Lion Specialized Hospital, Addis Ababa, Ethiopia. Depression Research
and Treatment, article ID 184902. Retrieved from https://doi.org/10.1155/2015/184902
[18] Thour, A., Das, S., Sehrawat, T., et al. (2015). Depression among patients with diabetes mellitus in North
India evaluated using patient health questionnaire-9. Indian Journal of Endocrinology and Metabolism,
vol. 19, no. 2, pp. 252–255. Retrieved from https://dx.doi.org/10.4103{%}2F2230-8210.149318
[19] Nagabhirava, G., Umate, M., Nimkar, S., et al. (2017). Depression and anxiety as comorbid disorders in
patients with type ii diabetes. International Journal of Medical Science and Public Health, vol. 6, no.
3, pp. 544–548. doi:10.5455/ijmsph.2017.0956304102016
[20] Mendenhall, E., Norris, S. A., Shidhaye, R., et al. (2014). Depression and type 2 diabetes in low- and
middle-income countries: a systematic review. Diabetes Research and Clinical Practice, vol. 103, no.
2, pp. 276–285. Retrieved from https://doi.org/10.1016/j.diabres.2014.01.001
[21] Bai, X., Liu, Z., Li, Z., et al. (2018). The association between insulin therapy and depression in patients
with type 2 diabetes mellitus: a meta-analysis. BMJ Open, vol. 8, no. 11, p. e020062. Retrieved from
http://dx.doi.org/10.1136/bmjopen-2017-020062
[22] Darwish, L., Beroncal, E., Sison, M. V., et al. (2018). Depression in people with type 2 diabetes: current
perspectives. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy, vol. 11, pp. 333–343.
Retrieved from https://dx.doi.org/10.2147{%}2FDMSO.S106797
[23] Azeze, G. A., Adema, B. G., Adella, G. A., et al. (2020). Factors associated with untreated depression
among type 2 diabetic patients at Halaba Kulito Hospital, South Ethiopia: a cross-sectional study.
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy, vol. 13, pp. 2189–2198. Retrieved
from https://dx.doi.org/10.2147{%}2FDMSO.S255360
[24] Arambwela, M. H., Somasundaram, N. P., Jayasekara, H. B. P. R., et al. (2019). Prevalence of depression
and associated risk factors among patients with type 2 diabetes attending the diabetic clinic at the
tertiary care hospital in Sri Lanka: a descriptive study. Psychiatry Journal, article ID 7468363. Retrieved
from https://doi.org/10.1155/2019/7468363
[25] Lloyed, C. E., Nouwen, A., Sartorious, N., et al. (2018). Prevalence and correlates of depressive disorders
in people with Type 2 diabetes: results from the International Prevalence and Treatment of Diabetes
and Depression (INTERPRET ‐DD ) study, a collaborative study carried out in 14 countries. Diabetes
Medicine. Retrieved from https://doi.org/10.1111/dme.13611
[26] Andreoulakis, E., Hyphantis, T., Kandylis, D., et al. (2012). Depression in diabetes mellitus: a
comprehensive review. Hippokratia, vol. 16, no. 3, pp. 205–214.
[27] World Health Organization. (2017). Addressing comorbidity between mental disorders and major
noncommunicable diseases. Retrieved from https://www.euro.who.int/en/publications/abstracts/
addressing-comorbidity-between-mental-disorders-and-major-noncommunicable-diseases-2017
(accessed on August 07, 2020).
[28] Andreoulakis, E., Hyphantis, T., Kandylis, D., et al. (2012). Depression in diabetes mellitus: a
comprehensive review. Hippokratia, vol. 16, no. 3, pp. 205–214. Retrieved from https://www.ncbi.nlm.
nih.gov/pmc/articles/PMC3738724/pdf/hippokratia-16-205.pdf
DOI 10.18502/sjms.v15i4.8163 Page 417
